Barbara A. Reeves, Esq., CEDS (Certified E-Discovery Specialist) has 30 years of intellectual property experience. Her experience began in connection with litigation involving the interaction between antitrust (her specialty at the time) and patent law. She has since handled many cases involving antitrust and patent claims and counterclaims, as well as trade secret claims, and counseled clients on the intersection of trade secret, contract, antitrust and patent law.
As an arbitrator, mediator, and special master, Ms. Reeves has successfully applied her skills to the settlement of numerous intellectual property matters. She has handled the spectrum of IP cases from patent to copyright and proprietary trade secret matters.
In addition, she has experience in such diverse industries as oil and gas, voice recognition, semiconductors, advertising, television programming and pharmaceuticals.
- Numerous trade secret theft cases arising out of misappropriated computer data, hiring away of corporate executives, joint ventures and corporate acquisitions
- Dispute involving voice recognition patented technology
- Patent dispute involving licensing of technology used in flat screen panels
- Copyright disputes involving music sampling
- Dispute involving biosimilars approval pathway impact of patent term
- Patent dispute involving trade association development of industry standards
- Dispute involving patentability of biological invention using established scientific processes
- Dispute involving patent infringement/invalidity of traffic control technology
- Patent infringement dispute between two online game developers
- Dispute involving patentability of diagnostic method of treatment patent
- Joint venture dispute involving the development and marketing of a point-of-care screening test
- Dispute between manufacturer and distributor over clothing line designs (included copyright issues and contract issues)
- Marketing dispute involving off-label use of patented drug
- Contract dispute between drug sponsor and clinical trials company involving technical, regulatory and performance issues
- Contract dispute involving pharmaceutical supply chain performance issues, including patent issues
- Dissolution and post-dissolution trademark and contractual claims among members of professional partnership
- Product-hopping dispute involving antitrust and patent issues between patentee and generic drug manufacturer